Grape King Bio Ltd (1707.TW)
Taiwan · TWD · Healthcare · Drug Manufacturers - Specialty & Generic
NT$83.80 (-1.64%) as of
Key statistics
- Market cap
- 12.41B
- P/E (TTM)
- 10.90
- Forward P/E
- 11.90
- EPS (TTM)
- 7.69
- Dividend yield
- 7.04%
- 52-week range
- 83.50 – 130.00
- Beta
- 0.23
- Revenue (TTM)
- 10.12B
- Profit margin
- 11.34%
- Volume
- 589.79k
About Grape King Bio Ltd
Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company provides health products and supplements; and microbial fermentation for mushroom mycelium, probiotics, and enzymes. It also offers functional ingredients for intestinal care, immunity regulation, liver care, brain health, eye care, weight control, feminine health, sensual health care, and others. It serves pharmaceutical preparations, finished drugs, oral liquids, and beverages and health foods. The company was founded in 1969 and is headquartered in Taoyuan City, Taiwan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Taoyuan City, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.